Medpace Holdings ROE - Return on Equity 2014-2025 | MEDP
- Medpace Holdings average return on equity for 2024 was 54.29, a 22.72% decline from 2023.
- Medpace Holdings average return on equity for 2023 was 70.25, a 79.76% decline from 2022.
- Medpace Holdings average return on equity for 2022 was 39.08, a 89.34% increase from 2021.
Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.